Author:
Lentzas Aristeidis,Venekamp Nikkie,Beijnen Jos H.,van Tellingen Olaf
Reference23 articles.
1. The impact of ATP-binding cassette transporters in the diseased brain: Context matters;Baltira;Cell Rep Med,2024
2. ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery;Schulz;Pharmacol. Rev.,2023
3. R.P. Dash, R. Jayachandra Babu, N.R. Srinivas, Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies, Eur J Drug Metab Pharmacokinet, 42 (2017) 915-933. doi: 10.1007/s13318-017-0411-4.
4. Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar;Kuhnle;J. Med. Chem.,2009
5. Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines;Linke;Int. J. Mol. Sci.,2022